Accueil > Actualité
Actualite financiere : Actualite bourse

Novartis: security label reinforced for Beovu in the EU

( - Novartis has announced that the CHMP has approved an update to the safety label of its Beovu (brolucizumab) to include information regarding retinal vasculitis and retinal vascular occlusion.

This update is applicable in the 27 EU member states, as well as the UK, Norway, Iceland and Lichtenstein. Beovu is now approved in wet LDMA in over 40 countries, including the US, the EU and Japan.

Copyright (c) 2020 All rights reserved.




Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.
Indices et cours différés d’au moins 15 mn | Cotations boursières fournies par ABC Bourse.